Current Science

Open Access Open Access  Restricted Access Subscription Access

Beyond Crispr:Single Base Editors for Human Health and Crop Improvement


Affiliations
1 Department of Genetics and Plant Breeding, Ch. Charan Singh University, Meerut - 250 004, India
 

During 2016–2018, CRISPR/Cas9 technology was modified using disabled Cas9 with nickase activity in combination with cytosine/adenine deaminases for the development of four generations of cytosine base editors (BE1–BE4) for C → U conversion and at least seven generations of adenine base editors (ABE1–ABE7) for A → I conversion. These base editors exhibited improved efficiency and reduced frequency of deletions among the products. Further improvement in the form of enhanced base editors and high-fidelity base editors was achieved through the use of 1-3 copies of uracil N-glycosylase inhibitors and phage Mu-Gam protein. The technology will bring precision to gene editing technology for human healthcare and crop improvement.

Keywords

AID/APOBEC, Base Editing, CRISPR/Cas9, Cytidine/Adenine Deaminases, Target AID.
User
Notifications
Font Size

  • Gaj, T., Gersbach, C. A. and Barbas, C. F., ZFN, TALEN and CRISPR/Cas-based methods for genome engineering. Trends Biotech., 2013, 31, 397-405.

  • Zetsche, B. et al., Cpf1 is a single RNA-guided endonuclease of a Class 2 CRISPR-Cas system. Cell, 2015, 163, 759-771.

  • Zaidi, S., Mahfouz, M. M. and Mansoor, M., CRISPR-Cpf1: A new tool for plant genome editing. Trends Plant Sci., 2017, 22, 550-553.

  • Waltz, E., CRISPR-edited crops free to enter market, skip regulation. Nat. Biotechnol., 2016, 34, 582.

  • Waltz, E., Gene-edited CRISPR mushroom escapes US regulation. Nature, 2016, 532, 293-293.

  • Hall, S. S., Editing the mushroom. Sci. Am., 2016, 314, 57-63.

  • Shi, J. et al., ARGOS8 variants generated by CRISPR-Cas9 improve maize grain yield under field drought stress conditions. Plant Biotech. J., 2017, 15, 207-216.

  • Nishida, K. et al., Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science, 2016, 353, aaf8729.

  • Satomura, A. et al., Precise genome-wide base editing by the CRISPR nickase system in yeast. Sci. Rep., 2017, 7, 2095; doi:10.1038/s41598-017-02013-7.

  • Komor, A. C. et al., Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 2016, 533, 420-424.

  • Gaudelli, N. M. et al., Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature, 2017, 551, 464-471.

  • Cox, D. B. T. et al., RNA editing with CRISPR. Science, 2017, 358, 1019-1027.

  • Saey, T. H., New CRISPR gene editors can fix RNA and DNA one typo at a time. Sci. News, 25 October 2017.

  • Ledford, H., David Lui: Gene corrector in '10 people who mattered this year'. Nature's 10. Nature, 2017, 552, 315-324.

  • Kleinstiver, B. P. et al., Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature, 2015, 523, 481-485.

  • Kim, D. et al., Digenome-seq: genome-wide profiling of CRISPRCas9 off-target effects in human cells. Nat. Methods, 2015, 12, 237-342.

  • Komor, A. C. et al., Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity. Sci. Adv., 2017, 3, eaao4774.

  • Wang, L. et al., Enhanced base editing by co-expression of free uracil DNA glycosylase inhibitor. Cell Res., 2017, 27, 1289- 1292.

  • Ran, F. A. et al., In vivo genome editing using Staphylococcus aureus Cas9. Nature, 2015, 520, 186-191.

  • Nishimasu, H. et al., Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science, 2018; 10.1126/science.aas9129 aas9129.

  • Hu, J. H. et al., Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature, 2018, 556, 57-63.

  • Kleinstiver, B. P. et al., Broadening Staphylococcus aureus Cas9 targeting range by modifying PAM recognition. Nat. Biotechnol., 2015, 33, 1293-1298.

  • Kleinstiver, B. P. et al., High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature, 2016, 529, 490-495.

  • Liang, P. et al., Effective gene editing by high-fidelity base editor 2 in mouse zygotes. Protein Cell, 2017, 8, 601-611.

  • Rees, H. A. et al., Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery. Nat. Commun., 2017, 8, 15790, doi:10.1038/ncomms15790.

  • Hall, S. S., The embarrassing destructive fight over biotech's big breakthrough. Sci. Am., 4 February 2016.

  • Liang, P. et al., Correction of β-thalassemia mutant by base editor in human embryos. Protein Cell, 2017, 8(11), 811-822.

  • Zeng et al., Correction of the marfan syndrome pathogenic FBN1 mutation by base editing in human cells and heterozygous embryos. Mol. Ther., 2018, 11; https://doi.org/10.1016/j.ymthe.2018.08.007.

  • Liang, P. et al., Effective and precise adenine base editing in mouse zygotes, Protein Cell, 2018, 9(9); doi:10.1007/s13238-0180566-z.

  • Cohen, J., Novel CRISPR-derived 'base editors' surgically alter DNA or RNA, offering new ways to fix mutations. Sci. News, 25 October 2017.

  • Shimatani, Z. et al., Targeted base editing in rice and tomato using a CRISPR-Cas9 cytidine deaminase fusion. Nat. Biotechnol., 2017, 35, 441-443.

  • Ren, B. et al., A CRISPR/Cas9 toolkit for efficient targeted base editing to induce genetic variations in rice. Sci. China. Life Sci., 2017, 60, 516-519.

  • Ren, B. et al., Improved base editor for efficiently inducing genetic variations in rice with CRISPR/Cas9-guided hyperactive hAID mutant. Mol. Plant, 2018, 11, 623-626.

  • Yan, F. et al., Highly efficient A•T to G•C base editing by Cas9nguided tRNA adenosine deaminase in rice. Mol. Plant, 2018, 11, 631-634.

  • Tang, W. and Liu, D. R., Rewritable multi-event analog recording in bacterial and mammalian cells. Science, 2018, 360, eaap8992; doi:10.1126/science.aap8992

  • Kwon, D., USDA will not regulate CRISPR-edited crops. The Scientist, 2 April 2018

  • Callaway, E., EU law deals blow to CRISPR crops, Nature, 2018, 560, 16.

  • Zong, Y. et al., Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion. Nat. Biotechnol., 2017, 35, 438-440.

  • Kim, Y. B. et al., Increasing the genome- targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat. Biotechnol., 2017, 35, 371-376.

  • Park, D. S. et al., Targeted base editing via RNA-guided cytidine deaminases in Xenopus laevis embryos. Mol. Cells, 2017, 40, 823- 827.

  • Ma, Y. et al., Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells. Nat. Methods, 2016, 13, 1029-1035.

  • Lu, Y. and Zhu, J. K., Precise editing of a target base in the rice genome using a modified CRISPR/Cas9 system. Mol. Plant, 2017, 10, 523-525.

  • Li, J. et al., Generation of targeted point mutations in rice by a modified CRISPR/Cas9 system. Mol. Plant, 2017, 10, 526-529.


Abstract Views: 300

PDF Views: 95




  • Beyond Crispr:Single Base Editors for Human Health and Crop Improvement

Abstract Views: 300  |  PDF Views: 95

Authors

P. K. Gupta
Department of Genetics and Plant Breeding, Ch. Charan Singh University, Meerut - 250 004, India

Abstract


During 2016–2018, CRISPR/Cas9 technology was modified using disabled Cas9 with nickase activity in combination with cytosine/adenine deaminases for the development of four generations of cytosine base editors (BE1–BE4) for C → U conversion and at least seven generations of adenine base editors (ABE1–ABE7) for A → I conversion. These base editors exhibited improved efficiency and reduced frequency of deletions among the products. Further improvement in the form of enhanced base editors and high-fidelity base editors was achieved through the use of 1-3 copies of uracil N-glycosylase inhibitors and phage Mu-Gam protein. The technology will bring precision to gene editing technology for human healthcare and crop improvement.

Keywords


AID/APOBEC, Base Editing, CRISPR/Cas9, Cytidine/Adenine Deaminases, Target AID.

References





DOI: https://doi.org/10.18520/cs%2Fv116%2Fi3%2F386-397